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  The Role of Reactive Oxygen 
Species
    For many years, reactive oxygen 
species (ROS), including superoxide, 
hydrogen peroxide, and hydroxyl 
radicals, and their reaction products, 
were classically described as harmful 
by-products of aerobic metabolism 
capable of causing DNA mutations, 
lipid peroxidation, and protein 
oxidation [1]. The identiﬁ  cation of 
enzymes such as superoxide dismutase, 
catalase, and peroxidase that served 
to eliminate these waste products 
rather substantiated this view. It soon 
became clear, however, that there 
existed a family of enzymes whose 
function it was to deliberately generate 
ROS. The ﬁ  rst of these was NADPH 
oxidase, which is responsible for the 
respiratory burst in neutrophils and 
macrophages in response to microbes 
or inﬂ  ammatory cytokines [2]. The 
catalytic centre of NADPH oxidase 
is the membrane-associated protein 
gp91phox (see Glossary) complexed with 
p22phox. Activation requires association 
with a phosphorylated form of p47phox 
(also known as Ncf1), p67phox, and 
the small GTPase Rac (Figure 1). 
p47phox deﬁ  ciency in humans leads to 
neutrophil dysfunction and chronic 
granulomatous disease (CGD), a 
primary immunodeﬁ  ciency disorder 
characterised by the inability to 
eradicate bacterial infections [3]. Since 
the late 1990s, six human gp91phox 
homologues have been identiﬁ  ed, each 
with distinct functions [1]. 
    Besides a role in phagocyte function 
and host defence, a large amount 
of evidence points to important 
roles for ROS in cell proliferation, 
apoptosis, angiogenesis, endocrine-
related functions, and oxidative 
modiﬁ  cation of the extracellular 
matrix. Indeed, increased ROS 
have been documented at sites of 
inﬂ  ammation, such as synovial joints 
of patients with inﬂ  ammatory arthritis 
(e.g., rheumatoid arthritis [RA]), and 
circulating neutrophils and monocytes 
from patients with RA have increased 
NADPH oxidase activity [4,5]. 
    Interestingly, polyarthritis has also 
been described in patients with CGD. 
More recently, induction of arthritis 
in mice deﬁ  cient for the p47phox 
subunit of NADPH oxidase was shown 
to induce granulomatous synovitis 
and exaggerated matrix destruction 
associated with enhanced expression of 
inﬂ  ammatory mediators [6]. Although 
the mechanism for this paradoxical 
relationship between deﬁ  cient NADPH 
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  Figure 1.   Structure and Function of the NADPH Oxidase Complex 
    Schematic of the molecular composition of the NADPH oxidase complex. The principal subunits 
are shown, together with some of the key cellular and molecular modiﬁ  cations that arise following 
activation of stress pathways and the generation of superoxide (O2
−). Two molecules of superoxide 
can react to generate hydrogen peroxide (H2O2). In the presence of iron, superoxide and H2O2 
react to generate hydroxyl radicals (OH•). Through their effects on protein modiﬁ  cation and lipid 
peroxidation, reactive oxygen species exert pleiotropic effects on multiple molecular and cellular 
pathways.  
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oxidase activity and inﬂ  ammatory 
arthritis has not been elaborated 
until now, these ﬁ  ndings certainly 
imply a more complex role for the 
NADPH oxidase complex in chronic 
inﬂ  ammation than previously thought.
    Oxidative Burst Capacity and 
Inﬂ  ammatory Arthritis
    Chronic inﬂ  ammatory syndromes 
such as RA are complex polygenic 
diseases in which it is proposed that 
inheritance of gene polymorphism 
predisposes to distinct phenotypes such 
as the magnitude of the inﬂ  ammatory 
response, the development of 
autoantibodies, or destruction of 
cartilage and bone. One productive 
approach for screening for such gene 
polymorphism has been to deﬁ  ne in 
relevant rodent models chromosomal 
segments associated with each disease 
phenotype. Multiple backcrossing of 
these chromosomal segments to the 
disease-prone strain generates congenic 
animals, which are invaluable tools for 
further study. For example, linkage 
analysis in rats susceptible or resistant 
to pristane-induced arthritis (PIA, an 
inﬂ  ammatory arthritis induced with 
the alkane oil pristane) has deﬁ  ned 
quantitative trait loci (QTL) that 
associate with disease severity and 
cartilage destruction. 
    In 2003, Holmdahl and colleagues 
reported the results of a detailed 
analysis of one such QTL,   pia4  , which 
is implicated not only with arthritis, 
but also in rodent models of multiple 
sclerosis and uveitis [7]. Introduction 
of the 20cM   pia4   fragment from the 
arthritis-resistant E3 strain into arthritis-
prone DA rats by serial backcrosses 
substantially reduced arthritis severity. 
By positional cloning, two structural 
polymorphisms of the   Ncf1   gene 
(encoding p47phox) were identiﬁ  ed 
in arthritis-susceptible DA rats 
characterised at the amino acid level by 
M106V and M153T substitutions. While 
the allelic variant had no effect on   Ncf1   
gene expression, the disease-associated 
allele conferred an unexpected 
reduction in oxidative burst upon 
stimulation of rat peritoneal cells with 
phorbol ester, presumably through the 
effects of the mutations on the function 
of the NADPH oxidase complex. 
Strikingly, this defective respiratory 
burst could be reversed in vivo by 
treating arthritis-prone DA rats with 
phytol, an alkane similar to pristane but 
that induces a robust reactive oxygen 
burst. Treatment not only restored the 
respiratory burst but also protected rats 
from developing arthritis. 
    A New Rodent Study
    In a new rodent study in   PLoS Medicine  , 
Holmdahl and colleagues explore 
in more detail the relationship 
between oxidative burst capacity 
and predisposition to inﬂ  ammatory 
arthritis in an approach that has 
implications for better understanding 
this paradoxical relationship in humans 
[8]. First, they compared how alkane 
derivatives such as pristane and phytol 
function in terms of oxidative burst 
capacity and arthritogenicity, and 
discovered that arthritis induction 
was independent of oxidative burst. 
Thus, while both phytol and pristane 
were potent inducers of oxidative 
burst in granulocytes in vitro, pristane 
induced, whereas phytol protected 
rats from disease. Importantly, phytol 
treatment restored the oxidative burst 
of Ncf1DA rats to levels observed in 
splenic granulocytes carrying the Ncf1E3 
protective allele, whilst phytol induced 
only very modest increases in ROS 
production in T cells. 
    Second, the authors explored the 
effects of phytol in different arthritis 
models, including collagen-induced 
arthritis, anti-collagen II antibody-
induced arthritis, and non-oil collagen-
induced arthritis, demonstrating both 
protective and therapeutic effects 
in all models; similar effects were 
observed in rats with normal oxidative 
burst capacity. Treatment resulted 
in reduction of the inﬂ  ammatory 
response, attenuation of cell-mediated 
immunity, and downregulation of 
markers of cartilage destruction, 
modifying clinical disease to an extent 
at least as good as methotrexate or 
TNF blockade (now considered gold-
standard therapy for RA). Histological 
analysis of joint sections conﬁ  rmed the 
joint-protecting effects of phytol. 
    Finally, an elegant series of 
experiments involving the transfer 
of T cells from pristane-inoculated 
rats to unmanipulated donor 
animals demonstrated, among other 
things, that the effects of phytol on 
arthritogenic T cells were rapid, since 
treatment of the donor T cells with 
phytol for as little as three hours was 
sufﬁ  cient to prevent the development 
of arthritis in recipient rats. By contrast, 
adoptive transfer of a mixture of T 
cells from control and phytol-treated 
animals failed to inhibit arthritis, 
suggesting that the disease-modifying 
effects of phytol on T cells are cell 
intrinsic, affecting only those cells 
directly exposed to the therapeutic 
agent.
  Study  Implications
    Why should enhancing oxidative burst 
and ROS production paradoxically 
ameliorate arthritis? There are 
several possible explanations, none of 
which would necessarily be mutually 
exclusive. We know, for example, 
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that deﬁ  ciency of   Ncf1   in mice and 
humans predisposes to repeated 
insult with infectious pathogens [3,9]. 
Accordingly, chronic subclinical 
infection in Ncf1DA rats could explain 
predisposition to disease through 
persistent activation of innate immune 
responses. However, the authors 
argue that arthritis occurs in both 
conventional and speciﬁ  c pathogen-
free facilities with equivalent severity, 
implying that the impact of deﬁ  cient 
versus mutant   Ncf1   gene products 
on host immunity might be distinct. 
Detailed analysis of the response of 
  Ncf1   congenic rat strains to challenge 
with bacterial pathogens should now be 
undertaken to rule this out. 
    Another conundrum arising from 
this work is the strikingly different 
levels of ROS induced in granulocytes 
and T cells after treatment with phytol 
in vitro; effects on T cell ROS levels 
were modest at best. So how could 
phytol regulate T cell reactivity? 
There is literature pointing to indirect 
effects of granulocyte- or macrophage-
derived ROS on T cell phenotype and 
function. For example, coculture of T 
cells with ROS-producing neutrophils 
reduces T-cell reactivity as well as 
cytokine and proliferative responses 
[10]. At the molecular level, several 
mechanisms might be implicated, 
including alterations of expression or 
function of key T cell receptor (TCR)–
signalling molecules including the 
TCR ζ chain and the transmembrane 
adaptor protein linker for activation 
of T cells (LAT) [10–12]. The 
oxidation status of T cells exposed to 
extracellular ROS might also inﬂ  uence 
the function of phosphatases that 
are known to be exquisitely sensitive 
to the oxidation of cysteine in the 
catalytic site [13]. This in turn might 
alter thresholds of T-cell reactivity. 
Increased susceptibility to apoptosis 
associated with exaggerated oxidative 
burst has also been reported, but this 
does not appear to be playing a major 
role in Holmdahl and colleagues’ rat 
models. Finally, we should not exclude 
the possibility that Ncf1 could play 
a role in as-yet undeﬁ  ned NADPH 
oxidase–independent pathways, 
perhaps exerting a negative regulatory 
role on intracellular signals involved in 
immune homeostasis.
    One intriguing possibility may 
relate to recent ﬁ  ndings suggesting 
that cell surface thiols (–SH) are 
targets of redox regulation [14], which 
could directly inﬂ  uence thresholds 
of T-cell reactivity [15]. According 
to this model, a “normal” oxidising 
extracellular environment would favour 
oxidation of cell surface molecules 
and receptors, thereby maintaining T 
cells in check. Under conditions that 
predispose to a defective oxidative 
burst (which would include inheritance 
of   Ncf1   mutations), increased surface 
thiols would lower thresholds of T cell 
activation, permitting uncontrolled 
expansion of effector T cells in vivo. 
This would presumably inﬂ  uence 
thymic development as well, since 
lowering TCR-signalling thresholds 
selects a repertoire of T cells that might 
otherwise die by neglect when failing to 
receive appropriate survival signals. 
    These intriguing results are 
important because they illustrate 
another means whereby redox 
reactions might be manipulated in 
the clinic. This would be especially 
attractive if, as this study demonstrates, 
the effects are rapid and reversible, 
because robust immunological and 
molecular tools are already available 
to monitor such interventions. This 
approach would be all the more 
appealing if genetic variation of 
subunits of the NADPH oxidase 
complex is associated with susceptibility 
to autoimmunity in humans. While the 
data provide unambiguous evidence 
for a dual role for the oxidative burst in 
innate and adaptive immune responses, 
it is now abundantly clear that waste 
products are not all bad.   
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